News and Press Releases
Eisbach and Cancer Focus Fund Announce $4.5m Investment to Support First-in-Human Phase 1/2 Trial of EIS-12656 for Refractory Advanced Solid Tumours
Eisbach is enabling the potential of synthetic lethality by developing novel compounds to exploit molecular vulnerabilities uniquely present in many hard-to-treat cancers 21 March 2024 -- Martinsried, Germany and Texas, US...
Category: Biotechnology, Pharmaceutical
Posted: March 21, 2024
Element launches cutting-edge Rapid Response Pharmaceutical Testing Service
21 March 2024 – Manchester, UK – Element, a global leader in materials testing, inspection, and certification services, is thrilled to announce the launch of its groundbreaking Rapid Response Pharmaceutical...
Category: Biotechnology
Posted: March 21, 2024
ArgusEye introduces AugaOne to accelerate downstream bioprocess development
AugaOne sensor system provides specific, real-time and automated data to reduce mAb process development time New sensor will be exhibited at the Bioprocessing Summit, 18-21 March 2024, booth 66. 21...
Category: Biotechnology
Posted: March 21, 2024
Nuclera joins Tech Nation’s Future Fifty Programme
Nuclera recognised as one of UK’s most exciting growth stage companies Official launch of 2024 cohort taken place at 10 Downing Street 19 March 2024 – Cambridge, UK – Nuclera,...
Category: Biotechnology, Drug Discovery
Posted: March 20, 2024
Experimental gene therapy for giant axonal neuropathy shows promise in NIH clinical trial
Treatment for rare childhood disease was well tolerated and slowed loss of motor function 20 March 2024 -- Maryland, US -- An investigational gene therapy for a rare neurodegenerative disease...
Category: Clinical Trials, Drug Discovery
Posted: March 20, 2024
SPT Labtech to co-market streamlined NGS library preparation workflows for both PCR and PCR-free applications with Roche
19 March 2024 – Cambridge, UK – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, announces its co-marketing...
Category: Biotechnology, Drug Discovery
Posted: March 20, 2024
SPT Labtech Ltd. Melbourn Science Park Melbourn Hertfordshire SG8 6HB United Kingdom
Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo
Cognizant’s AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors 19 March 2024...
Category: Biotechnology, Drug Discovery
Posted: March 20, 2024
Office Cognizant Technology Solutions World Headquarters Glenpointe Centre West 500 Frank W Burr Blvd Teaneck 07666 NJ
SolasCure Awarded £405k Innovate UK Biomedical Catalyst Grant to Advance Chronic Wound Care
Funding will be used to further optimise Aurase Wound Gel for future clinical trials SolasCure aims to deliver the first efficacious, cost-effective and pain-free solution for millions of patients suffering...
Category: Biotechnology
Posted: March 20, 2024
Faller Packaging publishes its 21st sustainability report
14 March 2024 – In the 21st edition of its sustainability report, Faller Packaging shows that small things can make a big difference. Last year went well for the company:...
Category: BioManufacturing, Drug Delivery, Logistics, Manufacturing and Packing
Posted: March 20, 2024
Semarion introduces SemaCyte Multiplexing Platform to enhance cell assay data quality and speed during drug discovery
Expansion to SemaCyte Microcarrier platform enables optical barcoding and pooling of adherent cells to augment drug discovery high-content imaging and other screening processes Access available through Semarion’s Early Adopter Programme....
Category: Drug Discovery
Posted: March 20, 2024
New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year
The new facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day 18 March 2024 – Bangalore,...
Category: BioManufacturing, Biotechnology, Drug Discovery
Posted: March 19, 2024
Biocon Park, SEZ, Bommasandra Industrial Area – Phase-IV, Jigani Link Road, Bangalore, Karnataka – 560 099
CARBOGEN AMCIS announces successful ANVISA audit of its facility in China
19 March 2024 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the successful completion of its first Brazilian Regulatory...
Category: BioManufacturing
Posted: March 19, 2024
Kindeva Drug Delivery Welcomes Jennifer Riter, New Vice President of Analytical Services
18 March 2024 -- Minnesota, US, and Missouri, US -- Kindeva Drug Delivery, a global leader in drug-device combination products, today welcomes Jennifer Riter as vice president of Analytical Services to...
Category: Drug Delivery
Posted: March 18, 2024
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
Next-generation suite enhances research productivity and innovation across chemical, pharmaceutical and biotechnology industries and academia Seamless integration within Revvity Signals Research platform empowers multidisciplinary discoveries. 18 March 2024 -- Massachusetts,...
Category: Biotechnology
Posted: March 18, 2024
Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies
Arrayjet’s patented spot-on-spot microarray screening technology is available for customers to adopt in-house and via Arrayjet’s CRO/CMO services. Immunome signs deal to use Arrayjet platform in its in-house screening operations...
Category: Biotechnology, Drug Discovery
Posted: March 18, 2024
